
Trump Signs Executive Order to Accelerate Psychedelic Research and Patient Access
President Trump signs executive order directing FDA to fast-track psychedelic research, provides $50 million for ibogaine studies, and opens Right to Try pathway for patients with treatment-resistant mental illness.










